INCY $64.26 -0.56 (-0.86%)
Tue, Dec 18, 2018
Incyte Corp is a Health Care stock that trades on the NASDAQ with a market cap of $6.48 Billion
Incyte focuses on the discovery and development of small-molecule drugs. The firm's lead drug, Jakafi, treats two types of rare blood cancer and is partnered with Novartis. Incyte's other marketed drugs include rheumatoid arthritis treatment Olumiant, which Eli Lilly licenses, and oncology drug Iclusig for chronic myeloid leukemia. Incyte's pipeline includes a broad array of oncology and autoimmune programs, including next-generation JAK inhibitor itacitinib. http://www.incyte.com
Incyte Corp Stock Charts
The 5 year and 1 year stock charts are below.
50 Day Moving Average
The 50 Day Moving Average is at $65.18 which is 1.41% above the stock price of $64.26.
200 Day Moving Average
The 200 Day Moving Average is at 69.50 which is 7.54% abovethe stock price of $64.26.
Because both the 50 DMA and 200 DMA are above the current stock price, this can be considered a bearish technical indicator.
INCY Stock Price
Below are a few key dates for the stock price.
Year To Date
The most recent stock price is $64.26.
The Year To Date (YTD) return is -36.31%.
52 Week Low
The 52 Week Low stock price is $60.85 set on Tue, May 1, 2018 which is 232 days ago.
The current price per share is 5.60% above the 52 week low.
52 Week High
The 52 Week High stock price is $100.98 set on Wed, Jan 3, 2018 which is 350 days ago.
The current price per share is -36.36% below the 52 week high.
All Time High
The All Time High stock price is $152.66 set on Wed, Mar 15, 2017 which is 644 days ago.
The current price per share is -57.91% below the all time high.
INCY Stock Split History
Incyte Corp has had 2 stock splits.
|Split Date||Split Ratio|
|Fri, Sep 1, 2000||1 to 2|
|Mon, Nov 10, 1997||1 to 2|
Below is the EPS, P/E Ratio and Earnings Date.
The Earnings Per Share (EPS) is $0.14.
The Price To Earnings (P/E) Ratio is 0.00.
Stocks can make big percentage moves on the earnings announcement.
Companies announce earnings either before the market open or after the close.
The Earnings Release Date for Incyte Corp was Tue, Jul 31, 2018.
Since this earnings release 141 days ago, the stock price is down by -6.30%.
Many investors know the importance of a companies earnings report. Also, the market reaction to the earnings release can be even more important and can help in making a prediction of a future price forecast of the shares.
A significant post earnings announcement percentage move can continue or reverse an existing trend for several days or weeks after the earnings date.
The most recent Earnings Release Date was on Tue, Oct 30, 2018, which was 50 days ago.
Since this earnings date, the stock price is up by +1.48%.
Incyte Corp Dividend
Below is important Dividend information.
INCY currently does not pay a dividend.
You may like this list of best dividend stocks of 2018.
Below are some other Biotech & Pharma industry stocks like Incyte Corp.